BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

292 related articles for article (PubMed ID: 33663081)

  • 21. A novel fusion gene involving PDGFRB and GCC2 in a chronic eosinophilic leukemia patient harboring t(2;5)(q37;q31).
    Iriyama N; Takahashi H; Naruse H; Miura K; Uchino Y; Nakagawa M; Iizuka K; Hamada T; Hatta Y; Nakayama T; Takei M
    Mol Genet Genomic Med; 2019 Apr; 7(4):e00591. PubMed ID: 30697976
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genomic and clinical findings in myeloid neoplasms with PDGFRB rearrangement.
    Di Giacomo D; Quintini M; Pierini V; Pellanera F; La Starza R; Gorello P; Matteucci C; Crescenzi B; Fiumara PF; Veltroni M; Borlenghi E; Albano F; Forghieri F; Maccaferri M; Bettelli F; Luppi M; Cuneo A; Rossi G; Mecucci C
    Ann Hematol; 2022 Feb; 101(2):297-307. PubMed ID: 34859285
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Multiple
    Sheng G; Zeng Z; Pan J; Kou L; Wang Q; Yao H; Wen L; Ma L; Wu D; Qiu H; Chen S
    Mol Cytogenet; 2017; 10():4. PubMed ID: 28261327
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Successful treatment with imatinib for a patient with myeloid neoplasms with eosinophilia and abnormalities of PDGFRB due to t (5;14)(q33;q22)].
    Fujii T; Ohno N; Matsui T; Kitahara S; Kobayashi S; Sahara N; Sakamoto N; Matsunaga T
    Rinsho Ketsueki; 2021; 62(11):1635-1638. PubMed ID: 34866089
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Modern diagnosis and treatment of primary eosinophilia.
    Tefferi A
    Acta Haematol; 2005; 114(1):52-60. PubMed ID: 15995325
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Test Utilization Approach to the Diagnostic Workup of Isolated Eosinophilia in Otherwise Morphologically Unremarkable Bone Marrow: A Single Institutional Experience.
    Fang H; Ketterling RP; Hanson CA; Pardanani A; Kurtin PJ; Chen D; Greipp PT; Howard MT; King RL; Van Dyke DL; Reichard KK
    Am J Clin Pathol; 2018 Oct; 150(5):421-431. PubMed ID: 30032299
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [The study of 4 cases of myeloid neoplasm with t (5;12) (q33;p13) and the literatures review].
    Kou L; Pan J; Qiu H; Chen S; Cen J; Zhang J; Bai S; Wu C; Wu Y; Gong Y; Shen J
    Zhonghua Xue Ye Xue Za Zhi; 2016 Apr; 37(4):302-7. PubMed ID: 27093993
    [TBL] [Abstract][Full Text] [Related]  

  • 28. TRIP11-PDGFRB fusion in a patient with a therapy-related myeloid neoplasm with t(5;14)(q33;q32) after treatment for acute promyelocytic leukemia.
    Kim HG; Jang JH; Koh EH
    Mol Cytogenet; 2014; 7(1):103. PubMed ID: 25606057
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Fusion of PRKG2 and SPTBN1 to the platelet-derived growth factor receptor beta gene (PDGFRB) in imatinib-responsive atypical myeloproliferative disorders.
    Gallagher G; Horsman DE; Tsang P; Forrest DL
    Cancer Genet Cytogenet; 2008 Feb; 181(1):46-51. PubMed ID: 18262053
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Myeloid neoplasm with eosinophilia and rearrangement of platelet-derived growth factor receptor beta gene in children: Two case reports.
    Wang SC; Yang WY
    World J Clin Cases; 2021 Jan; 9(1):204-210. PubMed ID: 33511186
    [TBL] [Abstract][Full Text] [Related]  

  • 31. EBF1-PDGFRB fusion in pediatric B-cell precursor acute lymphoblastic leukemia (BCP-ALL): genetic profile and clinical implications.
    Schwab C; Ryan SL; Chilton L; Elliott A; Murray J; Richardson S; Wragg C; Moppett J; Cummins M; Tunstall O; Parker CA; Saha V; Goulden N; Vora A; Moorman AV; Harrison CJ
    Blood; 2016 May; 127(18):2214-8. PubMed ID: 26872634
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Systemic mastocytosis associated with acute myeloid leukaemia.
    Fong C; Tong M
    Pathology; 2010; 42(5):485-7. PubMed ID: 20632831
    [No Abstract]   [Full Text] [Related]  

  • 33. Systemic mastocytosis (SM) associated with chronic eosinophilic leukemia (SM-CEL): detection of FIP1L1/PDGFRalpha, classification by WHO criteria, and response to therapy with imatinib.
    Florian S; Esterbauer H; Binder T; Müllauer L; Haas OA; Sperr WR; Sillaber C; Valent P
    Leuk Res; 2006 Sep; 30(9):1201-5. PubMed ID: 16406018
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic mastocytosis with associated acute myeloid leukemia with t (8; 21) (q22; q22).
    Gadage VS; Kadam Amare PS; Galani KS; Mittal N
    Indian J Pathol Microbiol; 2012; 55(3):409-12. PubMed ID: 23032848
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Novel translocations that disrupt the platelet-derived growth factor receptor beta (PDGFRB) gene in BCR-ABL-negative chronic myeloproliferative disorders.
    Baxter EJ; Kulkarni S; Vizmanos JL; Jaju R; Martinelli G; Testoni N; Hughes G; Salamanchuk Z; Calasanz MJ; Lahortiga I; Pocock CF; Dang R; Fidler C; Wainscoat JS; Boultwood J; Cross NC
    Br J Haematol; 2003 Jan; 120(2):251-6. PubMed ID: 12542482
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long-term Remission of Acute Myeloid Leukemia Developed From Systemic Mastocytosis by Conventional Chemotherapy.
    Yamada A; Kinoshita M; Sawa D; Saito Y; Kamimura S; Miyachi H; Moritake H
    J Pediatr Hematol Oncol; 2019 Aug; 41(6):e402-e404. PubMed ID: 30044348
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Intrahepatic cholestasis due to systemic mastocytosis: a case report and review of literature.
    Safyan EL; Veerabagu MP; Swerdlow SH; Lee RG; Rakela J
    Am J Gastroenterol; 1997 Jul; 92(7):1197-200. PubMed ID: 9219799
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Response to imatinib mesylate in patients with chronic myeloproliferative diseases with rearrangements of the platelet-derived growth factor receptor beta.
    Apperley JF; Gardembas M; Melo JV; Russell-Jones R; Bain BJ; Baxter EJ; Chase A; Chessells JM; Colombat M; Dearden CE; Dimitrijevic S; Mahon FX; Marin D; Nikolova Z; Olavarria E; Silberman S; Schultheis B; Cross NC; Goldman JM
    N Engl J Med; 2002 Aug; 347(7):481-7. PubMed ID: 12181402
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Therapy-related myeloid neoplasm in an 18-year-old boy with B-lymphoblastic leukemia.
    Qing X; Panosyan E; Yue C; Ji P; Gotesman M; French S; Cai J
    Exp Mol Pathol; 2017 Dec; 103(3):263-266. PubMed ID: 29155023
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
    Zou YS; Hoppman NL; Singh ZN; Sawhney S; Kotiah SD; Baer MR
    Cancer Genet; 2017 Apr; 212-213():38-44. PubMed ID: 28449810
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.